Baxter Internationalvs.Boston Scientific
BAX vs BSX · both in Medtech & devices, part of the Medicine, pharma & life science value chain: Medical equipment and devices, from surgery and cardiology to robotics.
Boston Scientific is about 5.0× larger than Baxter International by market cap; year to date, Baxter International leads (+25.4% vs −56.4%).
Side by side
| BAX | BSX | |
|---|---|---|
| Market cap | $12.2B | $60.7B |
| Price | $23.90 | $42.04 |
| Today | −0.3% | +1.1% |
| Return YTD | +25.4% | −56.4% |
| Return 1Y | +4.7% | −56.6% |
| Since June 26, 2026 | +8.4% | −5.0% |
| P/E | — | 16.5 |
| P/S | 1.1 | 2.9 |
| P/B | 2.0 | 2.4 |
Data as of 2026-10-08 · updates daily after U.S. close
Since June 26, 2026: the change in the closing price, from the daily closes Sectivia records itself since that date.
The two companies
Baxter InternationalBAX
Infusion pumps and the fluids that run through them are the anchor. Baxter also supplies dialysis therapy and products for surgery and acute care.
Full BAX profile →Boston ScientificBSX
Cardiology drives the growth, particularly electrophysiology, where Farapulse sits, and structural heart treatment. Endoscopy and urology cover the rest of the range.
Full BSX profile →More BAX & BSX comparisons
Other head-to-heads in the Medtech & devices segment.